Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 875 of 1631 entries
View as:

Multi-academic Center Study of Xofigo Patients

Phase: N/A Priority: Normal
NCT ID: NCT03419442 Org: User:
Start: 12/03/18 End: 10/22/19 Due: 10/22/20

Sorafenib Dose Escalation in Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00618982 Org: User:
Start: 02/29/08 End: 01/31/11 Due: 01/31/12

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00160043 Org: User:
Start: 03/31/05 End: 11/30/08 Due: 11/30/09

Phase IIa Study of Copanlisib in Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Phase: N/A Priority: Normal
NCT ID: NCT02455297 Org: User:
Start: 08/24/15 End: 08/31/16 Due: 08/31/17

Phase I Study on Rivaroxaban Granules for Oral Suspension Formulation in Children

Phase: N/A Priority: Normal
NCT ID: NCT02497716 Org: User:
Start: 11/04/15 End: 05/22/18 Due: 05/22/19

International PMS Study - KOGENATE Bayer

Phase: N/A Priority: Normal
NCT ID: NCT00864552 Org: User:
Start: 12/31/02 End: 12/31/05 Due: 12/31/06

Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose of 10 mg Immediate Release Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

Phase: N/A Priority: Normal
NCT ID: NCT04320771 Org: User:
Start: 11/02/17 End: 12/17/18 Due: 12/17/19

An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting

Phase: N/A Priority: Normal
NCT ID: NCT05471830 Org: User:
Start: 11/30/22 End: 12/01/23 Due: 12/01/24

Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and Patients

Phase: N/A Priority: Normal
NCT ID: NCT00961831 Org: User:
Start: 04/15/09 End: 12/16/09 Due: 12/16/10

Investigate the Responsiveness of the Erectile Quality Scale to Vardenafil Flexible Dose vs Placebo in Males With Erectile Dysfunction (ED)

Phase: N/A Priority: Normal
NCT ID: NCT00665340 Org: User:
Start: 07/31/04 End: 01/31/05 Due: 01/31/06

A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Participants (Part A). By Labeling BAY1817080 With a Radioactive Substance (Carbon 14) Researchers Want to Learn How the Study Drug is Processed and Excreted by the Body After Dosing (Part B)

Phase: N/A Priority: Normal
NCT ID: NCT04487431 Org: User:
Start: 08/05/20 End: 02/11/21 Due: 02/11/22

Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00086775 Org: User:
Start: 07/31/03 End: 10/31/09 Due: 10/31/10

Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction

Phase: N/A Priority: Normal
NCT ID: NCT02652091 Org: User:
Start: 02/05/16 End: 09/13/17 Due: 09/13/18

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT01874431 Org: User:
Start: 06/12/13 End: 08/07/14 Due: 08/07/15

Sun Protection Factor Assay (SPF Assay 18676)

Phase: N/A Priority: Normal
NCT ID: NCT02825030 Org: User:
Start: 12/10/15 End: 12/17/15 Due: 12/17/16

An Observational Study to Assess Quality of Life and Satisfaction of Young Women (Aged 18-29) Following 6 (±1) Months Using Jaydess as Their Contraceptive Method

Phase: N/A Priority: Normal
NCT ID: NCT02574715 Org: User:
Start: 09/18/15 End: 09/28/16 Due: 09/28/17

A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy.

Phase: N/A Priority: Normal
NCT ID: NCT00668096 Org: User:
Start: 05/31/04 End: 01/31/05 Due: 01/31/06

LEVITRA® Specific Drug Use Investigation. To Investigate the Safety Profile in Combination Use With Alpha-blockers

Phase: N/A Priority: Normal
NCT ID: NCT01207947 Org: User:
Start: 10/31/07 End: 03/31/10 Due: 03/31/11

Bioequivalence Study for Acarbose / Metformin FDC

Phase: N/A Priority: Normal
NCT ID: NCT01728740 Org: User:
Start: 09/30/12 End: 12/31/12 Due: 12/31/13

Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem

Phase: N/A Priority: Normal
NCT ID: NCT00492726 Org: User:
Start: 07/31/06 End: 02/28/09 Due: 02/28/10

Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)

Phase: N/A Priority: Normal
NCT ID: NCT02550717 Org: User:
Start: 09/01/15 End: 03/31/17 Due: 03/31/18

Safety and Efficacy of SH T00660AA in Treatment of Endometriosis

Phase: N/A Priority: Normal
NCT ID: NCT00225186 Org: User:
Start: 07/31/04 End: 03/31/08 Due: 03/31/09

Effects of Phenylephrine on Nasal Congestion in Participants With Seasonal Allergic Rhinitis (P08156 AM2)(Completed)

Phase: N/A Priority: Normal
NCT ID: NCT01330017 Org: User:
Start: 03/31/11 End: 06/30/11 Due: 06/30/12

Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)

Phase: N/A Priority: Normal
NCT ID: NCT00360490 Org: User:
Start: 07/31/06 End: 06/30/08 Due: 06/30/09

Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT00782470 Org: User:
Start: 12/31/07 End: 11/30/10 Due: 11/30/11